AI
ABBVIE INC
ABBV· Health Care· BiotechnologyS&P 500
Close · 12/11/2026
294.45
1D
-0.18%52-week range
190.75 – 302.93
Volume
48,26,600.00
Price history
ABBV
14/10/2026 to 12/11/2026
O 299.30 H 300.42 L 294.07
1W+2.15%
1M+3.87%
3M+18.03%
6M+39.70%
1Y+30.77%
3Y+107.13%
5Y+151.54%
MAX+176.01%
Fundamentals
as of 12/11/2026- Market cap
- $520.47B
- Shares out
- 1.77B
- P/E (trailing)
- 50.33
- P/E (forward)
- 18.22
- EPS (trailing)
- 5.85
- Dividend yield
- 2.35%
- Beta
- 0.19
- Profit margin
- 15.67%
- P/B
- -113.78
SEC financial statements
59 quarterly and 15 annual periods through 30/09/2026.
Details
- Ticker
- ABBV
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
26 filers · 2 on watchlist · 42 buys · 41 sells · 1 option · ?: 11 · D: 41 · R: 31
- 14/09/2026Pete SessionsSellAbbVie Inc. Common Stock$15,001–$50,000
- 27/03/2026Alan ArmstrongBuyAbbVie Inc. Common Stock$15,001–$50,000
- 05/05/2026Josh GottheimerWSellAbbVie Inc. Common Stock$1,001–$15,000
- 18/12/2025Julie JohnsonSellAbbVie Inc. Common Stock$1,001–$15,000
- 08/12/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 28/04/2025Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000
- 24/01/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000